title: Outcomes of middle meatal antrostomy after different surgical strategies.
abstract: CONCLUSIONS
  There was no significant difference in the postoperative outcomes between different surgical options for treating chronic maxillary sinusitis (CMS).
  
  
  OBJECTIVE
  We aimed to compare the improvement in symptoms, and changes in endoscopic and CT grade in patients undergoing different surgical management of the maxillary sinus ostium.
  
  
  METHODS
  In 32 patients (group A), the pathologic mucosa was radically removed with a power microdebrider. In 28 patients (group B), only part of the pathologic mucosa was removed; gross pathologic lesions were left in situ. In 38 patients (group C), only enlargement of the maxillary ostium was performed. Pre- and postoperative changes in symptoms, endoscopic polyp grade, and Lund-Mackay CT score were compared between groups.
  
  
  RESULTS
  In all groups, the symptoms were significantly improved after 1 month and throughout the follow-up period. Patients in groups A and B had meaningful improvement of the endoscopic polyp grade 1 month after surgery. The endoscopic grade of patients in group C at 1 and 3 months after surgery was not significantly different from the preoperative grade; however, there was a meaningful difference after 6 months. At 12 months after surgery, all groups had a significant decrease in the CT score (p < 0.01); however, there was no difference between groups.
authors.affiliation: Department of Otorhinolaryngology-Head and Neck Surgery, Inha University School of Medicine, Incheon, Korea.
authors.forename: Young Hyo
authors.initials: YH
authors.lastname: Kim
authors.forename: Gihwa
authors.initials: G
authors.lastname: Jung
authors.forename: Seok Jae
authors.initials: SJ
authors.lastname: Lee
authors.forename: Byoung-Youn
authors.initials: BY
authors.lastname: Ko
authors.forename: Tae Young
authors.initials: TY
authors.lastname: Jang
mesh_terms: D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D002908:Chronic Disease; D004724:Endoscopy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008443:Maxillary Sinus / Q000601:surgery; D015523:Maxillary Sinusitis / Q000175:diagnosis / Q000601:surgery*; D008875:Middle Aged; D000068656:Mometasone Furoate; D055556:Nasal Lavage; D059085:Nasal Sprays; D011182:Postoperative Care; D011183:Postoperative Complications / Q000209:etiology*; D011244:Pregnadienediols / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D059085:Nasal Sprays; D011244:Pregnadienediols; D000068656:Mometasone Furoate